Attached files

file filename
EX-31.1 - OxySure Therapeutics, Inc.f10q0615ex31i_oxysure.htm
10-Q - QUARTERLY REPORT - OxySure Therapeutics, Inc.f10q0615_oxysure.htm
EX-31.2 - OxySure Therapeutics, Inc.f10q0615ex31ii_oxysure.htm

Exhibit 32

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of OxySure Systems, Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Julian T. Ross, President and Chief Financial Officer of the Company, respectively, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.   The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.   The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: August 19, 2015

 

/s/ Julian T. Ross  
Julian T. Ross,  
President and Chief Financial Officer